Enhanced depressor response to nitric oxide in the rostral ventrolateral medulla of spontaneously hypertensive rats

Hypertension
S KagiyamaM Fujishima

Abstract

Possible impairment of the L-arginine-nitric oxide (NO) pathway in the rostral ventrolateral medulla of adult spontaneously hypertensive rats (SHR) was investigated by microinjecting N(G)-nitro-L-arginine methyl ester (L-NAME), NOC 18 (an NO donor), or L-arginine. Unilateral injection of L-NAME (10 nmol/50 nL) into the rostral ventrolateral medulla significantly increased mean arterial pressure (MAP) in both SHR and Wistar-Kyoto rats (WKY). The increases in MAP did not differ significantly between the two strains (15+/-3 versus 10+/-2 mm Hg, respectively; n=8). In contrast, microinjection of L-arginine elicited significant (P<.05) dose-dependent decreases in MAP in both strains, and these depressor responses were significantly greater in SHR than in WKY (in 10 nmol of L-arginine: -29+/-2 versus -15+/-2 mm Hg, respectively; n=8, P<.01). Similarly, microinjection of NOC 18 (10 nmol/50 nL) reduced MAP in both strains, and the depressor response was also significantly greater in SHR than in WKY (-38+/-7 versus -22+/-3 mm Hg, respectively; n=8, P<.05). These results suggest that the L-arginine-NO pathway in the rostral ventrolateral medulla is impaired in SHR and that this impairment may contribute to the increase in arterial pressu...Continue Reading

References

Jan 23, 1992·Biochimica Et Biophysica Acta·Y NagataT Akino
Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·R Tabrizchi, C R Triggle
Nov 1, 1991·The Journal of Clinical Investigation·P Y Chen, P W Sanders
Nov 1, 1991·Clinical Science·A CalverP Vallance
Oct 31, 1991·Biochemical and Biophysical Research Communications·C M VenturiniS Moncada
Oct 28, 1991·Neuroscience Letters·L N ShapovalL S Pobegailo
Dec 1, 1991·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·R SchleifferA Gairard
Jul 1, 1991·Hypertension·T NabikaY Yamori
Jul 9, 1991·European Journal of Pharmacology·G A BöhmeJ C Blanchard
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D D ReesS Moncada
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R G KnowlesS Moncada
Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Dec 30, 1993·The New England Journal of Medicine·S Moncada, A Higgs
Dec 1, 1994·Acta Physiologica Scandinavica·T Jun, A Wennmalm
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·M J SchellS H Snyder
Apr 11, 1995·The American Journal of Physiology·K NakamuraA Aviv
Dec 15, 1994·Biochemical and Biophysical Research Communications·Y WakabayashiH Takahashi
Jan 1, 1994·The American Journal of Physiology·T HornA V Ferguson
Mar 1, 1996·American Journal of Hypertension·C L CabreraD F Bohr
Oct 23, 1997·Brain Research. Molecular Brain Research·D Plochocka-Zulinska, T L Krukoff

❮ Previous
Next ❯

Citations

Nov 13, 2009·Bulletin of Experimental Biology and Medicine·V M Chertok, A E Kotsyuba
Sep 30, 2006·Molecular and Cellular Biochemistry·Silvie HojnáJaroslav Kunes
Jul 17, 1999·Brain Research. Brain Research Reviews·T L Krukoff
Jan 23, 1999·Current Opinion in Nephrology and Hypertension·M Sander, R G Victor
May 8, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yoshitaka HirookaAkira Takeshita
Dec 22, 1999·The Japanese Journal of Physiology·M MaedaM Nakai
Sep 14, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·Keisuke ShinoharaKenji Sunagawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.